In the Third in a New Series of Videos, Dr Pam Brown and Dr Kevin Fernando Discuss the Updated NICE Guideline 28 on Type 2 Diabetes
Theory in Practice (TIPs) videos are a new series of interviews in which Dr Kevin Fernando consults healthcare professionals about topical issues in primary care, asking two questions and agreeing two key take-home messages.
Key: GPwSI=GP with a special interest; SGLT-2=sodium–glucose co-transporter-2; GLP-1=glucagon-like peptide-1; ADA=American Diabetes Association; EASD=European Association for the Study of Diabetes; SU=sulfonylurea; DPP-4=dipeptidyl peptidase-4; DKA=diabetic ketoacidosis
In this TIPs video, Dr Kevin Fernando interviews Dr Pam Brown about the updated NICE Guideline 28 on the management of type 2 diabetes, asking two questions:
- How can the practice-changing recommendations of NICE Guideline 28 around early combination therapy be implemented?
- Where should GLP-1 receptor agonists sit in current treatment paradigms?
| Useful Resources |
|---|
| Note: At the time of publication (March 2022), some of the drugs discussed in this article did not have UK marketing authorisation for the indications discussed. Prescribers should refer to the individual summaries of product characteristics for further information and recommendations regarding the use of pharmacological therapies. For off-licence use of medicines, the prescriber should follow relevant professional guidance, taking full responsibility for the decision. Informed consent should be obtained and documented. See the General Medical Council’s Good practice in prescribing and managing medicines and devices for further information. |
If you would like to suggest a topic for a future TIPs video or even take part in one, get in touch at: ginp@webmd.net
| Reflect on your learning and download our Reflection record |
| Keen to Learn More? |
|---|
Read Dr Pam Brown and Dr Colin Kenny’s related article on the updated NICE Guideline 28. Key Learning Points: Managing Type 2 Diabetes in AdultsDr Pam Brown and Dr Colin Kenny Provide Seven Key Learning Points from the Updated NICE Guideline on the Management of Type 2 Diabetes |